Asfari M, Janjic D, Meda P, Li G, Halban P A, Wollheim C B
Department of Medicine, University of Geneva, Switzerland.
Endocrinology. 1992 Jan;130(1):167-78. doi: 10.1210/endo.130.1.1370150.
New insulin-secreting cell lines (INS-1 and INS-2) were established from cells isolated from an x-ray-induced rat transplantable insulinoma. The continuous growth of these cells was found to be dependent on the reducing agent 2-mercaptoethanol. Removal of this thiol compound caused a 15-fold drop in total cellular glutathione levels. These cells proliferated slowly (population doubling time about 100 h) and, in general, showed morphological characteristics typical of native beta-cells. Most cells stained positive for insulin and did not react with antibodies against the other islet hormones. The content of immunoreactive insulin was about 8 micrograms/10(6) cells, corresponding to 20% of the native beta-cell content. These cells synthesized both proinsulin I and II and displayed conversion rates of the two precursor hormones similar to those observed in rat islets. However, glucose failed to stimulate the rate of proinsulin biosynthesis. In static incubations, glucose stimulated insulin secretion from floating cell clusters or from attached cells. Under perifusion conditions, 10 mM but not 1 mM glucose enhanced secretion 2.2-fold. In the presence of forskolin and 3-isobutyl-1-methylxanthine, increase of glucose concentration from 2.8-20 mM caused a 4-fold enhancement of the rate of secretion. Glucose also depolarized INS-1 cells and raised the concentration of cytosolic Ca2+. This suggests that glucose is still capable of eliciting part of the ionic events at the plasma membrane, which leads to insulin secretion. The structural and functional characteristics of INS-1 cells remained unchanged over a period of 2 yr (about 80 passages). Although INS-2 cells have not been fully characterized, their insulin content was similar to that of INS-1 cells and they also remain partially sensitive to glucose as a secretagogue. INS-1 cells retain beta-cell surface antigens, as revealed by reactivity with the antigangloside monoclonal antibodies R2D6 and A2B5. These findings indicate that INS-1 cells have remained stable and retain a high degree of differentiation which should make them a suitable model for studying various aspects of beta-cell function.
新的胰岛素分泌细胞系(INS-1和INS-2)是从经X射线诱导的大鼠可移植胰岛素瘤中分离出的细胞建立的。发现这些细胞的持续生长依赖于还原剂2-巯基乙醇。去除这种硫醇化合物会导致细胞内总谷胱甘肽水平下降15倍。这些细胞增殖缓慢(群体倍增时间约为100小时),总体上呈现出天然β细胞典型的形态特征。大多数细胞胰岛素染色呈阳性,且不与其他胰岛激素的抗体发生反应。免疫反应性胰岛素的含量约为8微克/10⁶个细胞,相当于天然β细胞含量的20%。这些细胞合成胰岛素原I和II,并且两种前体激素的转化率与在大鼠胰岛中观察到的相似。然而,葡萄糖未能刺激胰岛素原生物合成的速率。在静态培养中,葡萄糖刺激悬浮细胞簇或贴壁细胞分泌胰岛素。在灌流条件下,10 mM葡萄糖而非1 mM葡萄糖使分泌增加2.2倍。在存在福斯可林和3-异丁基-1-甲基黄嘌呤的情况下,葡萄糖浓度从2.8 mM增加到20 mM导致分泌速率提高4倍。葡萄糖还使INS-1细胞去极化并提高胞质Ca²⁺浓度。这表明葡萄糖仍然能够引发质膜上的部分离子事件,从而导致胰岛素分泌。INS-1细胞的结构和功能特征在2年(约80代)的时间内保持不变。尽管INS-2细胞尚未得到充分表征,但其胰岛素含量与INS-1细胞相似,并且它们对作为促分泌剂的葡萄糖也仍部分敏感。如与抗神经节苷脂单克隆抗体R2D6和A2B5反应所显示,INS-1细胞保留β细胞表面抗原。这些发现表明INS-1细胞保持稳定并保留高度分化状态,这使其成为研究β细胞功能各个方面的合适模型。